Professor Maraisʼ research will focus on the DR-TB hotspot of Kiribati.
Every person aged 3 or older with TB disease or infection in the capital Tarawa will be treated to prevent the emergence and spread of DR-TB. Patients will be identified by tuberculin skin testing, chest X-ray and/or sputum testing.
The project team will also provide training and mentoring in 6 Pacific Island countries, to improve DR-TB care and prevention, and model the cost-effectiveness of different elimination strategies. The project will start in June 2020 and is funded for 4 years.
The research is being funded under the Medical Research Future Fundʼs Global Health Initiative, which focuses on AMR and DR-TB as threats to global and national health security.
TB is one of the oldest diseases known to man and has a devastating impact on people, families and communities